BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 21784826)

  • 1. Incompatible live-donor kidney transplantation in the United States: results of a national survey.
    Garonzik Wang JM; Montgomery RA; Kucirka LM; Berger JC; Warren DS; Segev DL
    Clin J Am Soc Nephrol; 2011 Aug; 6(8):2041-6. PubMed ID: 21784826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantifying the risk of incompatible kidney transplantation: a multicenter study.
    Orandi BJ; Garonzik-Wang JM; Massie AB; Zachary AA; Montgomery JR; Van Arendonk KJ; Stegall MD; Jordan SC; Oberholzer J; Dunn TB; Ratner LE; Kapur S; Pelletier RP; Roberts JP; Melcher ML; Singh P; Sudan DL; Posner MP; El-Amm JM; Shapiro R; Cooper M; Lipkowitz GS; Rees MA; Marsh CL; Sankari BR; Gerber DA; Nelson PW; Wellen J; Bozorgzadeh A; Gaber AO; Montgomery RA; Segev DL
    Am J Transplant; 2014 Jul; 14(7):1573-80. PubMed ID: 24913913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful kidney transplantation after desensitization using plasmapheresis, low-dose intravenous immunoglobulin, and rituximab in highly sensitized patients: a single-center experience.
    Jin MK; Cho JH; Kwon O; Hong KD; Choi JY; Yoon SH; Park SH; Kim YL; Kim CD
    Transplant Proc; 2012 Jan; 44(1):200-3. PubMed ID: 22310614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three-year outcomes following 1420 ABO-incompatible living-donor kidney transplants performed after ABO antibody reduction: results from 101 centers.
    Opelz G; Morath C; Süsal C; Tran TH; Zeier M; Döhler B
    Transplantation; 2015 Feb; 99(2):400-4. PubMed ID: 25050471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bortezomib in ABO-incompatible kidney transplant desensitization: a case report.
    Wong NL; O'Connell P; Chapman JR; Nankivell B; Kable K; Webster AC; Wong G
    Nephrology (Carlton); 2015 Mar; 20 Suppl 1():22-4. PubMed ID: 25807854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kidney transplant in highly sensitized patients after desensitization with plasmapheresis and low-dose intravenous immunoglobulin.
    Yuan XP; Wang CX; Gao W; Fu Q; He XS
    Exp Clin Transplant; 2010 Jun; 8(2):130-5. PubMed ID: 20565369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in ABO-incompatible kidney transplantation.
    Aikawa A; Saito K; Takahashi K
    Exp Clin Transplant; 2015 Apr; 13 Suppl 1():18-22. PubMed ID: 25894122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics of cellular and humoral immunity in a successful case of positive crossmatch kidney transplantation: a case report.
    Tanimine N; Ide K; Yamashita M; Tanaka Y; Igarashi Y; Banshodani M; Tazawa H; Basnet NB; Doskali M; Onoe T; Tashiro H; Ohdan H
    Transplant Proc; 2011; 43(6):2411-4. PubMed ID: 21839279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of desensitization methods: Rituximab with/without plasmapheresis in ABO-incompatible living donor liver transplantation.
    Lee EC; Kim SH; Shim JR; Park SJ
    Hepatobiliary Pancreat Dis Int; 2018 Apr; 17(2):119-125. PubMed ID: 29576278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ABO-Incompatible kidney transplantation.
    Yaich S
    Saudi J Kidney Dis Transpl; 2013 May; 24(3):463-72. PubMed ID: 23640616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Positive Donor-Specific HLA Antibodies Crossmatch on Graft Survival in ABO-Incompatible Liver-Kidney Transplantation: A Case Report.
    Hsieh CE; Yang Y; Lin KH; Chen CC; Ko CJ; Hsu YL; Lin CC; Hung YJ; Lin PY; Wang SH; Chen YL
    Transplant Proc; 2018 Dec; 50(10):4008-4011. PubMed ID: 30522859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perioperative Desensitization Improves Outcomes Among Crossmatch Positive Recipients of Deceased Donor Renal Transplants.
    Sharma A; King A; Kumar D; Behnke M; McDougan F; Kimball PM
    Prog Transplant; 2016 Jun; 26(2):157-61. PubMed ID: 27207404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Living donor kidney transplantation across positive crossmatch: the University of Illinois at Chicago experience.
    Thielke JJ; West-Thielke PM; Herren HL; Bareato U; Ommert T; Vidanovic V; Campbell-Lee SA; Tzvetanov IG; Sankary HN; Kaplan B; Benedetti E; Oberholzer J
    Transplantation; 2009 Jan; 87(2):268-73. PubMed ID: 19155983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome of ABO Blood Type-Incompatible Living-Related Donor Kidney Transplantation Under a Contemporary Immunosuppression Strategy in Japan.
    Hamano I; Hatakeyama S; Fujita T; Murakami R; Hamaya T; Togashi K; Suzuki Y; Yamamoto H; Yoneyama T; Yoneyama T; Hashimoto Y; Narumi S; Tomita H; Ohyama C
    Transplant Proc; 2020; 52(6):1700-1704. PubMed ID: 32448659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transplantation across previously incompatible immunological barriers.
    Magee CC
    Transpl Int; 2006 Feb; 19(2):87-97. PubMed ID: 16441356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes Following ABO-Incompatible Kidney Transplantation Performed After Desensitization by Nonantigen-Specific Immunoadsorption.
    Becker LE; Siebert D; Süsal C; Opelz G; Leo A; Waldherr R; Macher-Goeppinger S; Schemmer P; Schaefer SM; Klein K; Beimler J; Zeier M; Schwenger V; Morath C
    Transplantation; 2015 Nov; 99(11):2364-71. PubMed ID: 25989497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delayed graft function and acute rejection following HLA-incompatible living donor kidney transplantation.
    Motter JD; Jackson KR; Long JJ; Waldram MM; Orandi BJ; Montgomery RA; Stegall MD; Jordan SC; Benedetti E; Dunn TB; Ratner LE; Kapur S; Pelletier RP; Roberts JP; Melcher ML; Singh P; Sudan DL; Posner MP; El-Amm JM; Shapiro R; Cooper M; Verbesey JE; Lipkowitz GS; Rees MA; Marsh CL; Sankari BR; Gerber DA; Wellen JR; Bozorgzadeh A; Gaber AO; Heher EC; Weng FL; Djamali A; Helderman JH; Concepcion BP; Brayman KL; Oberholzer J; Kozlowski T; Covarrubias K; Massie AB; Segev DL; Garonzik-Wang JM
    Am J Transplant; 2021 Apr; 21(4):1612-1621. PubMed ID: 33370502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Individualized Preconditioning for ABO-Incompatible Living-Donor Kidney Transplantation: An Initial Report of 48 Cases from China.
    Wang XD; Liu JP; Fan Y; Song TR; Shi YY; Li YM; Lv YH; Li XH; Huang ZL; Lin T
    Ann Transplant; 2020 Feb; 25():e920224. PubMed ID: 32029699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative outcome analysis of ABO-incompatible and positive crossmatch renal transplantation: a single-center experience.
    Padmanabhan A; Ratner LE; Jhang JS; Duong JK; Markowitz GS; Vasilescu ER; Crew RJ; Schwartz J
    Transplantation; 2009 Jun; 87(12):1889-96. PubMed ID: 19543070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Desensitization with the Use of an Antibody Removal-Free Protocol in ABO-Incompatible Kidney Transplant Recipients with a Low Anti-A/B Antibody Titer.
    Nanmoku K; Shinzato T; Kubo T; Shimizu T; Kimura T; Yagisawa T
    Transplant Proc; 2018 May; 50(4):982-986. PubMed ID: 29731097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.